Big Names Take Hit on Theranos

Blood-testing company got much of its funding from high-profile private investors who weren’t part of the ecosystem that typically backs startups and could see their stakes wiped out.

from WSJ.com: US Business http://ift.tt/2gqqmZA
via IFTTT